Company profile: Automated Lab Solutions
1.1 - Company Overview
Company description
- Provider of life science robotics and automation, including the CellCelector automated system for fluorescence imaging, selection, and image-based sorting/picking of single cells, clusters, adherent cell colonies, and clones from semi-solid media; rare single cell isolation; single cell cloning; stem cell picking; the Incubator FlowBox laminar flow cabinet; and automation components.
Products and services
- CellCelector: A fully automated system for image-based sorting and picking of single cells, clusters, adherent colonies, and clones from semi-solid media, enabling fluorescence imaging, selection, and real-time image-based quality control
- Single Cell Cloning: A nanowell-based method that generates producer cell lines with image-verified monoclonality and viability proofs, delivering documented single-cell origin
- Rare Single Cell Isolation: An automated process for automatically detecting and isolating pure single rare cells for molecular characterization or culturing
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Automated Lab Solutions
Passage Bio
HQ: United States
Website
- Description: Provider of fully integrated gene therapy development focused on treatments for monogenic central nervous system diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Passage Bio company profile →
Geneseeq
HQ: Canada
Website
- Description: Provider of NGS-based genomic testing and research services for cancer care, offering pan-cancer and tumor-specific panels plus project design, sequencing and data analysis. Products include GeneseeqPrime™ (437-gene solid tumor panel with mutation, tumor mutational burden and DNA mismatch repair insights), GeneseeqPrime™ HRD for PARP inhibitor guidance, Hemasalus™ DNA/Hemarna™ RNA for hematological cancers, and Shielding™ ULTRA MRD ctDNA detection.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Geneseeq company profile →
Epistem
HQ: United Kingdom
Website
- Description: Provider of specialist contract research services supporting drug discovery and development, offering preclinical in vitro/in vivo models in oncology, inflammatory and gastrointestinal diseases (incl. GI toxicities); GCLP-accredited clinical trial support (histology, IHC, image analysis, gene expression, DNA genotyping); organoid models; cancer stem cell sphere assays; subcutaneous xenografts; orthotopic/metastatic bioluminescent models.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Epistem company profile →
BioLamina
HQ: Sweden
Website
- Description: Provider of cell culture matrices based on human recombinant laminins for primary cells and stem cell applications. Products include Biolaminin 521 LN and 521 MX for chemically defined, feeder-free self-renewal of human ES/iPS cells (LN: animal origin-free; MX: animal origin-free to the secondary level); 521 CTG for clinical studies and feeder-free culture of PSCs, MSCs, and progenitor cells; 111/121 LN as general attachment proteins; and 211 LN for tissue-specific cell growth and differentiation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioLamina company profile →
Mirati Therapeutics
HQ: United States
Website
- Description: Provider of biotechnology, based at 9363 Towne Centre Dr, San Diego, CA, United States.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mirati Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Automated Lab Solutions
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Automated Lab Solutions
2.2 - Growth funds investing in similar companies to Automated Lab Solutions
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Automated Lab Solutions
4.2 - Public trading comparable groups for Automated Lab Solutions
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →